NCT00741481|Completed
PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.
earlyPETmCRC
Evaluation of Prognostic and Predictive Value of PETSCAn in ColoRectal Cancer (CRC)
Loading search results
earlyPETmCRC
Evaluation of Prognostic and Predictive Value of PETSCAn in ColoRectal Cancer (CRC)
Sponsor study identifier
Secondary identifiers
observational
40
1 country
1
Study Start
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2010
Actual (reported)Study Completion
July 2010
Actual (reported)Study hypothesis : early decrease in fdg-pet measured SUV max after 1 cycle of chemotherapy can accurately predict response of chemotherapy as assessed by conventional radiology after 3 cycles of chemotherapy. FDG-PET imaging will be done at J0 and J14 of a new line of chemotherapy treatment in metastatic colorectal cancer. SUV max will be recorded and delta SUVmax will be compared to the results of conventional radiological evaluation after 3 courses of chemotherapy. Results will also be compared to the time to disease progression.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
August 25, 2008
Actual (reported)August 26, 2008
Actual (reported)July 2010
Actual (reported)July 2010
Actual (reported)compare fdg-pet variations after 1 course of chemotherapy to chemotherapy outcome measured by time to disease progression
Time to Disease progression
compare fdg-pet variations after 1 course of chemotherapy to chemotherapy outcome measured by tumour response rate following RECIST criteria.
response rate
all study population
FDG-PET imaging at D0 and D14 of first course of a new chemotherapy for advanced colorectal cancer
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients \>18 yrs old advanced evaluable colorectal cancer beginning a new line of chemotherapy
Institut Jules Bordet, Université Libre de Bruxelles
Brussels, 1190, Belgium
Alain - Hendlisz, MD
Institut Jules Bordet, Université Libre de Bruxelles, Brussels
First Submitted
August 25, 2008
First Posted
August 26, 2008
Study Start
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2010
Actual (reported)The Jules Bordet Institute Molecular Profiling Program Feasibility Trial
Contact the study team to confirm eligibility.
Study Completion
July 2010
Actual (reported)Last Updated
February 24, 2011
Record last verified: 2011-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: